Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living. According to our (Global Info Research) latest study, the global Novel Drug Delivery Systems market size was valued at USD 25000 million in 2022 and is forecast to a readjusted size of USD 27990 million by 2029 with a CAGR of 1.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent. In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc. This report is a detailed and comprehensive analysis for global Novel Drug Delivery Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Novel Drug Delivery Systems market size and forecasts, in consumption value ($ Million), 2018-2029 Global Novel Drug Delivery Systems market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Novel Drug Delivery Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Novel Drug Delivery Systems market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Novel Drug Delivery Systems To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Novel Drug Delivery Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Teva, Roche, UCB (Union Chimique Belge) and Celgene, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Novel Drug Delivery Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Liposomes PEGylated Proteins & Polypeptides Polymer Nanoparticle Proteinﾖdrug Conjugates Others Market segment by Application Hospitals & Clinic Cancer Treatment Centers Others Market segment by players, this report covers Amgen Teva Roche UCB (Union Chimique Belge) Celgene Merck Gilead Sciences Sanofi Pfizer Takeda Bausch&Lomb Samyang Biopharmaceuticals Johnson & Johnson TOLMAR Astellas AMAG Pharmaceuticals AbbVie Dr Reddy AstraZeneca Aspen Acrotech Biopharma TWi Pharmaceuticals Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Novel Drug Delivery Systems product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Novel Drug Delivery Systems, with revenue, gross margin and global market share of Novel Drug Delivery Systems from 2018 to 2023. Chapter 3, the Novel Drug Delivery Systems competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Novel Drug Delivery Systems market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Novel Drug Delivery Systems. Chapter 13, to describe Novel Drug Delivery Systems research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Novel Drug Delivery Systems 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Novel Drug Delivery Systems by Type 1.3.1 Overview: Global Novel Drug Delivery Systems Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Novel Drug Delivery Systems Consumption Value Market Share by Type in 2022
